Introduction: Age and years of education influence the risk of dementia and may impact the prognostic accuracy of mild cognitive impairment subtypes. Methods: Memory clinic patients without dementia (N 5 358, age 64.0 6 7.9) were stratified into four groups based on years of age (64 and 65) and education (12 and 13), examined with a neuropsychological test battery at baseline and followed up after 2 years. Results: The prognostic accuracy of amnestic multi-domain mild cognitive impairment for dementia was highest in younger patients with more years of education and lowest in older patients with fewer years of education. Conversely, conversion rates to dementia were lowest in younger patients with more years of education and highest in older patients with fewer years of education. Discussion: Mild cognitive impairment subtypes and demographic information should be combined to increase the accuracy of prognoses for dementia.
Background
Mild cognitive impairment (MCI) [1] is a clinical syndrome, characterized by a decline in cognitive function greater than what is considered normal and different from mild dementia in that activities of daily life are intact or only minimally disturbed. The risk of future dementia is elevated for persons with MCI [2, 3] . However, many memory clinic patients with MCI do not develop dementia, and an MCI classification yields many false positives [2] . To increase the specificity of the MCI classification and account for the heterogeneity inherent in the MCI syndrome, Petersen et al. [4] and Winblad et al. [5] proposed a subtype paradigm, in which MCI is further divided based on whether or not memory is impaired and whether one or several cognitive domains are affected. The resulting categories were amnestic single-domain (aMCI-sd), amnestic multi-domain (aMCI-md), nonamnestic single-domain (naMCI-sd), and nonamnestic multi-domain (naMCI-md) mild cognitive impairment. We previously reported that aMCI-md results in fewer false positives than nonsubtyped MCI and that the other subtypes have little or no prognostic value [6] .
Low education is a risk factor for dementia [7, 8] . Furthermore, dementia prevalence increases sharply with age, from 1.6% between 60 and 64 years of age, to 4.3% between 70 and 74 years, and 43.1% over the age of 90 [9] . This relationship is also evident in clinical samples [10] . However, there are also indications that both old age and fewer years of formal education attenuate the prognostic accuracy for dementia. Visser et al. [11] reported that the positive predictive value for various definitions of MCI in predicting Alzheimer's disease dementia (ADD) 5 years later was higher in patients older than 65 years, likely because of a higher prevalence of predementia in the older group. However, because both sensitivity and specificity were higher in the younger group, the results can also be interpreted as a better prognostic accuracy among younger participants. In another study, Visser et al. [12] reported good prognostic accuracy for subsequent ADD only for amnestic MCI in patients aged 70-85 years, as compared with patients under 69 years of age. Thus, it still remains unclear how patient age influences the prognostic accuracy in MCI. Furthermore, both neuritic plaques and neurofibrillary tangles measured postmortem [13, 14] and cerebrospinal fluid Alzheimer's disease biomarkers [15] are more weakly associated with an ADD diagnosis in older people; distinguishing between different states with increasing age is an increasingly difficult task.
In a large population-based study, neuropsychological test results predicted dementia in participants with higher but not lower educational levels [16] , possibly because of larger variability in cognitive performance in people with higher educational levels than people with lower educational levels. To the best of our knowledge, there are no clinical studies reporting prognostic accuracy in different education groups or in age and education groups simultaneously.
The aim of the present study was to investigate the influence of years of age and education on the prognostic accuracy of MCI subtypes over a 2-year period.
Materials and methods

Participants
We included 358 consecutive patients from the Gothenburg MCI study [17] , a prospective umbrella study conducted at the outpatient memory clinic at the Sahlgrenska University Hospital in Gothenburg, Sweden. First visits took place between 2000 and 2014. All participants were between 40 and 79 years old and experienced cognitive decline (self-reported and/or informant reported) without obvious relation to somatic or psychiatric disorders or traumatic brain injury, with duration of at least 6 months. Cognitive decline was assessed in a clinical interview. In the present study, we included participants who had completed the baseline diagnostic assessment and did not have manifest dementia at baseline (see Section 2.2 for details).
We also included healthy controls, primarily recruited from senior citizen organizations and via information meetings about dementia. Several controls were spouses of patients. All controls were thoroughly interviewed by a research nurse before inclusion. Controls were included if they were physically and mentally healthy and displayed neither self-reported symptoms nor observable signs of cognitive impairment.
In the Gothenburg MCI study, 742 patient participants were included between 2000 and the end of 2014. Of those, 223 participants (57% women, age at baseline 67. 4 
Procedures
Diagnostic procedures
We used the GDS [18] to determine the cognitive stage of the participants. In the Gothenburg MCI study version, GDS is operationalized using the MMSE [19] , the Clinical Dementia Rating [20] , the Stepwise Comparative Status Analysis (STEP) [21] , and the Investigation of Flexibility, which is a short form of the executive interview [22] .
A specialist physician or a registered nurse determined the GDS stage. GDS stage 4 was assigned if STEP was .1, Investigation of Flexibility was .3, Clinical Dementia Rating sum of boxes was .1.0, and MMSE was 25. GDS 4 is equivalent to Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, dementia criteria [23] . GDS stage 4 or higher at follow-up was considered conversion to dementia and was used as outcome or reference standard [24, 25] .
Instruments and testing procedure
A licensed psychologist or a psychologist in training, supervised by a licensed psychologist, administered the neuropsychological test battery to patients and controls. Two sessions of approximately 1.5-2 hours were needed to complete the examination. The test sequence was designed to minimize the risk of contamination on the memory tests. We used the Digit Symbol test from either the Wechsler Adult Intelligence Scale-revised [26] or the Wechsler Adult Intelligence Scale-3rd Edition [27] and the Trail-Making Test part B (TMT B) [28] to assess processing speed and attention; the delayed recall trials from the Wechsler Memory Scale Logical Memory subtest [29] and the Rey Auditory Verbal Learning Test [30] to assess verbal episodic memory; the copy condition of the Rey Complex Figure test [31] and the silhouettes subtest of the Visual Object and Space Perception Battery [32] to assess visuospatial function; the Boston Naming Test [33] and the Token test part 5 [34] to assess confrontation naming and comprehension of spoken language, respectively; and the interference part of the Stroop test, Victoria version (Stroop III) [35] , and the Parallel Serial Mental Operations test [36] to assess executive functions, parallel distributed processing, automaticity, inhibition, mental control, and tracking. In accordance with previously published papers from our group [6, [36] [37] [38] , we categorized TMT B as a test of complex attention rather than executive function. The tests in the battery are widely used in clinical settings and research settings and have appropriate reliability and validity [39] [40] [41] [42] .
Grouping procedures
Educational attainment and age at first visit
To investigate the prognostic accuracy of aMCI-md among younger vs. older participants and participants with more vs. less educational attainment, we stratified patients into groups based on years of age (64 5 "Young"; 65 5 "Old"), years of education (13 5 "Edu1"; 12 5 "Edu2"), and their combination (Young Edu1, Young Edu2, Old Edu1, and Old Edu2).
MCI subtypes
We used neuropsychological test data from the control group to calculate cutoff scores. In the control group, the younger participants scored significantly better on the Digit Symbol test from Wechsler Adult Intelligence Scalerevised and on Stroop III. Participants with more years of education scored significantly better on the Token test, the TMT B, and Stroop III. Thus, scores from the Digit Symbol test from Wechsler Adult Intelligence Scale-revised were corrected for age, scores from the Token test and TMT B were corrected for education, and Stroop III scores were corrected for both age and education (Table 1) . To account for deviations from the standard normal distribution, the test score cutoffs were calculated using percentiles. In this article, we will refer to the 93.3rd percentile as 1.5 standard deviations (SDs).
We used the criteria of Jak et al. [43] to construct the MCI subtype groups. aMCI-sd was operationalized as scoring 1.5 SD or more below the control mean on at least one memory test, with all nonmemory domain test scores above; aMCImd as scoring 1.5 SD below the control mean on at least one memory test as well as at least one nonmemory test; naMCI-sd as scoring 1.5 SD below the control mean on at least one test in any one nonmemory domain, with both memory test scores and scores in other domains above; naMCI-md as scoring 1.5 SD below the control mean on at least two tests in any two or more nonmemory domains but with both memory scores above. Patients with no test result 1.5 SD or more under the control mean were categorized as "no impairment". Furthermore, we grouped all patients belonging to any MCI subtype group as "non-subtyped MCI", that is, the complement group of "no impairment". The MCI subtypes were then used as predictor variables in the subsequent analyses.
Statistics
Prognostic accuracy is reported as true positive, false positive, false negative, and true negative observations, sensitivity, specificity, positive likelihood ratio (LR1), negative likelihood ratio (LR2), pretest probability, posttest probability for a positive test, posttest probability for a negative test, and clinical utility index for case finding (CUI1) and screening (CUI2). The clinical utility of the CUI can be interpreted as follows: 0.81, excellent; 0.64, good; 0.49, satisfactory; and ,0.49, poor [44] . When applicable, we also report receiver operating characteristic curves for graphic comparison of two or more binary diagnostic tests, employing a method described by Biggerstaff [45] .
For continuous comparisons, we used t-test and Tukey's test for multiple comparisons. Categorical dichotomous comparisons were done using the chi-square test and multiple comparisons using the Steel-Dwass test. Confidence intervals (CIs) were calculated using a method developed by Wilson [46] with the In Vitro Diagnostics Performance add-in for JMPÓ, version 13, software (SAS Institute, Cary, NC, 1989-2017), except for posttest probability CIs, where we used the online Diagnostic Test Calculator [47] .
Results
Baseline demographics in combined age and education groups and MCI subtypes
MMSE scores were significantly higher in Young Edu1 than those in both Old Edu1 and Old Edu2 ( Table 2 ). The aMCI-md group was significantly older than the "no impairment" group and naMCI-sd group, and the naMCI-md group was older than the "no impairment" group. The "no impairment" group had more years of education than both aMCI-md and naMCI-md. MMSE scores were lower in aMCI-md than in the "no impairment" group and naMCI-sd.
The distribution of subtypes in Young Edu1 was significantly different from that in Old Edu1 and Old Edu2, and the subtype distribution in Young Edu2 was significantly different from that in Old Edu2. The "no impairment" classification was the most common in the Young Edu1 group (52%), followed by the Young Edu2 group (40%); the Old Edu1 group (23%), and the Old Edu2 group (16%) (Fig. 1 ). The aMCI-md classification was the least common in the Young Edu1 group (11%), followed by the Young Edu2 group (22%); the Old Edu1 group (23%); and the Old Edu2 group (35%).
Conversion rates
The overall conversion rate or pretest probability of dementia for patients followed for 2 years was 18.9%, which corresponds to 9.5% per year. More Old participants (29%) than Young (11%) converted to dementia (c 2 P , .0001), and more Edu2 participants (26%) converted compared with Edu1 participants (13%; c 2 P value 5 .0023). The conversion rate after 2 years in the Young Edu1 group (6%) was significantly different from the conversion rate in the Old Edu2 group (34%, Steel-Dwass P value , .0001) and the Old Edu1 group (22%, Steel-Dwass P 5 .0036). The difference between Old Edu2 and Old Edu1 was nonsignificant. The conversion rate in the Young Edu2 group (17%) did not differ significantly from the other groups.
Prognostic accuracy
Among all patients, only the aMCI-md subtype had significant LR1 (4.6) and LR2 (0.4) ( Table 3) . Non-subtyped MCI also had significant LR1 (1.6) and LR2 (0.1).
Age groups and education groups
In both age groups, aMCI-md LR1 and LR2 were significant, with higher accuracy in the Young (LR1 6.1, LR2 0.4) than the Old (LR1 3.5, LR2 0.5) group (Table 3) . aMCI-sd had a significant LR1 (3.6) in the Old group. No other subtypes were significant, but for all tested categories, LR1 was higher, and LR2 was lower in the Young group.
For aMCI-md, LR1 and LR2 were significant in both education groups, with better accuracy in Edu1 (LR1 8.1, LR2 0.3) than Edu2 (LR1 3.1, LR2 0.5). No other results were significant, but for all tested categories, LR1 was higher and LR2 was lower in Edu1 (Table 3 ). 
Combined age and education groups
The subtype aMCI-md was a significant predictor of dementia in all combined age and education groups, with the highest LR1 and the lowest LR2 in Young Edu1 (LR1 15.2, LR2 0.0) ( Table 4 ). In Young Edu1, all subtypes but aMCI-md had LR1 0.0 and LR2 around or above 1.0 and were thus negatively associated with dementia. The subtype naMCI-sd was negatively associated with dementia in both Young Edu1 and Old Edu1 groups.
The receiver operating characteristic curves (Fig. 2 ) show that aMCI-md was overall better at predicting dementia than all other subtypes and non-subtyped MCI in the Young Edu1 (panel A) and the Old Edu1 (panel C) groups. In the Old Edu1 (panel C) group, aMCI-md was the only significant predictor. In the Young Edu2 (panel B) and the Old Edu2 (panel D) groups, non-subtyped MCI had a higher sensitivity, and aMCI-md had a higher specificity.
When comparing aMCI-md in the combined age and education groups (Fig. 2 , Panel E), it was best at predicting dementia in Young Edu1, followed by Old Edu1. Nonsubtyped MCI (Fig. 2, Panel F) was overall better at predicting dementia in Young Edu1 compared with the other groups, and overall worse in Old Edu1.
We also established MCI subtype groups stratified for age alone, education alone, and age and education simulta-neously for all tests and recalculated all parameters of prognostic accuracy. The results were similar to those presented here (results not shown).
Discussion
To our knowledge, no previous study has reported prognostic accuracy in a clinical sample as influenced by years of education, years of age, or years of age and education simultaneously. In the present study, we show that both age and years of education influence the prognostic accuracy of MCI and MCI subtypes.
The prognostic accuracy, or criterion validity, for both aMCI-md and non-subtyped MCI was the highest in the Young Edu1 group and the lowest in the Old Edu2 group. Conversely, annual conversion rates to dementia from aMCI-md were the lowest in the Young Edu1 group and the highest in the Old Edu2 group. Thus, with older age and fewer years of education at baseline, the rate of conversion to dementia increased, and the prognostic accuracy of aMCI-md and non-subtyped MCI decreased. The remaining subtypes provided no basis for prognosis. Furthermore, in older patients and in patients with fewer years of education, multi-impairment MCI was more common, and in younger patients and patients with more years of education, absence of cognitive impairments was commonplace. Differences in Fig. 1 . Prevalence of MCI subtypes in combined age and education groups. Abbreviations: aMCI-md, amnestic multi-domain mild cognitive impairment; aMCI-sd, amnestic single-domain mild cognitive impairment; Edu2, 12 years of education; Edu1, 13 years of education; naMCI-md, non-amnestic multi-domain mild cognitive impairment; naMCI-sd, non-amnestic single-domain mild cognitive impairment; Old, 65 years of age; Young, 64 years of age. NOTE. Young Edu1 was different from Old Edu2 (P .001) and Old Edu1 (P .05). Young Edu2 was different from Old Edu2 (P .01). Calculated with the Steel-Dwass test. subtype prevalence likely also partly explain the differences in conversion rates between the combined age and education groups.
In the separate comparisons of age and education, there were differences in prognostic accuracy, but they were smaller than when age and education were combined. For aMCI-md, both more years of education and a lower age increased the likelihood of an accurate prognosis. For nonsubtyped MCI, the prognostic accuracy was better among the younger patients. In one study, Visser et al. [12] reported a better prognostic accuracy in patients aged between 70 and 85 years than in patients aged between 40 and 69 years. In another study, Visser et al. [11] reported a better prognostic accuracy in patients aged between 55 and 64 years than between 65 and 85 years of age. These results are contradictory. Our results are in agreement with the latter study. The differences between Visser (2008) on the one hand and Visser (2005) and our results (better prognostic accuracy in younger patients) on the other could be explained in part by the choice of different cut-points between the age groups (65 vs. 70 years of age) but could also stem from differences in MCI criteria and outcome measures. We applied dementia as an outcome, regardless of etiology, whereas Visser et al. reported ADD only [11, 12] .
Furthermore, our results are in congruence with Chary et al. [16] , who concluded that prognostic accuracy was higher for dementia among cognitively normal participants with higher education than participants with lower education. Their data originated from a population-based study, and only a fraction (,10%) of the participants had MCI. Our study is, to our knowledge, the first to report similar results in memory clinic patients with MCI.
A better prognostic accuracy in younger people may have several explanations. For instance, Wisdom et al. [48] showed that variability in Wechsler Adult Intelligence Scale-IV subtest performance increased with age. This implies a reduced performance of any attempt to predict dementia based on neuropsychological test scores, as the error would grow larger with increasing age. That is, in younger patients, test performance may be more likely to reflect an actual pathological process, as opposed to natural variation and normal age-related functional changes. The intraindividual variability in cognitive function also increases with age [49] , which may result in lower reliability of classifications based on cognitive tests [43] . Furthermore, the occurrence of plaques and tangles in the brains of ADD patients decreases with increasing age but increases in healthy individuals [13, 14] , that is, the purported hallmarks of Alzheimer's disease become less disease-specific with increasing age. Deckers et al. [50] reported that known midlife risk factors and protective factors for dementia fail to predict dementia in persons aged more than 85 years. These factors may lead to a further blurring of the border between disease and health with increasing age, making any prognostic assessment increasingly difficult.
There are no universally applicable guidelines for desirable levels of sensitivity and specificity [51] , although some have called for sensitivities and specificities around 85% [52] . In our results, only aMCI-md in Young Edu1 patients reached those levels. In a clinical setting, a test that can reliably establish the presence or absence of disease as a basis for treatment decisions would be ideal. To achieve this, the positive clinical utility index (the product of sensitivity and post test probability if the test is positive) should be above 0.8 [44] . Our results indicate that no MCI subtype achieves this in memory clinic patients.
A strength of the present study is that it reports novel results, namely that age and education together and in combination impact the accuracy of a dementia prognosis based on MCI subtypes. The results are of clinical interest and may be used to infer clinical utility of MCI subtyping.
The study also has a few limitations. We used our own normative data for neuropsychological test variables, which might affect the generalizability of our results. Furthermore, both the index test (MCI subtype based on neuropsychological test results) and the reference standard (GDS 4, mild dementia) were based on cognitive tests, creating a slight risk of incorporation bias. Data collection was part of a large umbrella study and was undertaken without regard for statistical power to detect differences in prognostic accuracy. A larger sample size would likely result in smaller CIs and more precise parameter estimates. Furthermore, our results are derived from patients seeking care at a secondary-care memory clinic and might not be representative of the general population, thus conclusions should not be generalized outside of this specific setting. Also, with a larger sample, other independent predictor variables such as sex and biomarker status as well as specific dementia etiologies, for example, ADD and subcortical vascular dementia, could be incorporated into analyses of prognostic accuracy.
Conclusion
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RESEARCH IN CONTEXT
1. Systematic review: The authors reviewed the literature using traditional (e.g., PubMed) sources. Publications reporting measures of prognostic accuracy of mild cognitive impairment (MCI) subtypes for future dementia in polychotomized age and/or education groups are cited.
2. Interpretation: Our findings suggest that both years of age and years of education of a patient influence the prognostic accuracy of MCI subtypes.
3. Future directions: The influence of years of age and years of education on the prognostic accuracy of other predictors of dementia, that is, biomarker based MCI classifications, needs further attention.
